Beside ecdysone (1), ecdysterone (2) is one of the most common 5β-cholest-7-en-6-one (ecdysteroid) derivatives, which, besides having a hormonal effect on invertebrates, possesses a number of favorable non-hormonal biological effects on mammals. The most interesting of these is that on degenerative diseases, one of which, up to now not clarified in detail, is the so-called adaptogenic effect (protection of the organism against adverse stress factors) associated with anabolic, gastroprotective, and antioxidant effects. A second group of favorable effects is the possibility of suppression of neurodegenerative processes and protection of the cardiovascular system (metabolic syndrome symptom suppression, antidiabetic activity, and protection of heart and blood vessels). Because of these properties, ecdysterone has the potential to be developed as a medicinal agent.
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Introduction In 1954 the isolation of the insect prothoracic glands hormone, ecdysone (1) , which regulates the molting process of larvae, was published by Butenandt and Karlson after 10 years of intensive research [1] . Besides 25 mg of ecdysone (1), 2.5 mg of another, more polar substance, ecdysterone (2, 20-hydroxyecdysone) , was obtained, the structure of which was identified by Huber and Hoppe [2] . This was followed by further isolation and closer characterization of ecdysterone in the following short period [3] [4] [5] . Thus was started the era of intensive study of zooecdysteroids, hormonal substances regulating the physiological processes of all invertebrates. Over time it became apparent that some of these steroids, present in invertebrate tissues in trace concentrations (10 -7 -10 -6 M), are also products of higher plant metabolism. The concentration of these phytoecdysteroids ranges from 10 -3 to 10 -2 M, and perhaps even higher. About 7600 papers of various types have been published to date, including especially the isolation of ecdysteroids from animal and plant materials, their occurrence and structure identification, endocrinology, biological processes in invertebrates and vertebrates, molecular biology and cytogenetics, pharmacology, models for study of ecdysteroid activity, and possibilities for practical application. Around 440 ecdysteroids are known at present [6] , but ecdysterone is one of the most common, and numerous biological experiments have utilized this now commercially-available substance. It is for this reason that it is the subject of this review.
Approximately 4300 studies concerning ecdysterone (including more than 100 review papers and books, as well as more than 50 review articles devoted to phytoecdysteroids) have been published since ecdysone (1) was first isolated. In addition, working groups have produced monographs on ecdysteroids [7] , and reports on these compounds have also featured in books of abstracts of workshops specifically designed for these substances [8, 9] . These studies were devoted especially to biological effects on invertebrates. Only a small portion deals with pharmacological activity in vertebrates and a minimal number with humans [10, 11] . However, in the last ten years, the possibilities have been raised of this substance as a potential drug, agrochemical, and component of diagnostic preparations in human and veterinary medicine.
Chemical characteristics of ecdysterone and its metabolic fate in organisms
2β,3β,14α,20β,22α,25β-Hexahydroxycholest-7-en-6-one (2, ecdysterone, β-ecdysone, 20-hydroxyecdysone), a structurally-characteristic ecdysteroid [12] , is a white crystalline substance, poorly soluble in water. In comparision with cholesterol and β-sitosterol, this polar steroid should be better absorbed from the intestinal lumen, but exact values of biological availability in humans after p.o. administration are still not available.
By virtue of its marked polarity, unlike cholesterol, 2 is not soluble in fats, and hence cannot be distributed in chylomicron form. It is not easy to estimate the resorbability of steroid substances. For example, cholesterol and β-sitosterol differ only slightly in their aliphatic side chains, and their logP and solubility values are close, but the resorbability of β-sitosterol is significantly higher {apparently by reason that cholesterol is a substance of body origin, and that is why transmitter systems are exerted for it}. After the C 5 -C 6 double bond of β-sitosterol has been saturated to form β-sitostanol, no significant changes in the solubility and logP values occur (Table 1) , but the absorbability of β-sitostanol from the GIT is significantly lower than that of β-sitosterol. Assessment of the bio-availability of ecdysterone is complicated by the presence of a keto-group at C 6 and a double bond at C 7 . Because this substance is the result of organism metabolism and is also highly polar a relatively low bio-availability can be assumed. Determination of pharmacokinetic parameters of orally administered ecdysterone (0.2 mg/kg body weight, determination of RIA in urine) yielded values for IC of  1.4 h -1 , EC  0.48 h -1
and EHT  3.3 h. These are higher than those found for ecdysone (1) [13] . Vertebrates are not able to open the steroid skeleton metabolically. Enzymatic reactions occur, resulting in the production of a number of other substances, which can be conjugated before excretion in urine and feces [14] . After parenteral application of labeled ecdysterone, comparable amounts of the substance in feces and urine were found [15] . These differences in the elimination of the two very similar substances indicate the possibility of the influence of the OH group at C 20 on renal elimination (this position contributes also to other effects). However, this question has not yet been answered. After oral administration, ecdysteroids pass through the proximal part of the GIT without changes and their maximum level occurs from 30 minutes to 2 hours after administration [13] . Generally, they are eliminated quickly from blood; EHT values are 4 hours for ecdysone (1) and 9 hours for ecdysterone [15] . It appears that the metabolism of ecdysteroids is simple in vertebrates [14] . After i.p. administration of labeled ecdysone (1) to mice it was found that 55 % of this substance was metabolized [16] . In contrast to arthropods, in which a wider metabolic profile occurs, only a few metabolites appeared in the case of mice. In particular, 14-deoxyecdysone was found, which can be formed through intestinal flora action [16] , as well as in the metabolism of bile acids [17] . It is interesting that no polar conjugates were detected [13] . In the case of the diol aggregate in ecdysterone (C 20 -C 22 ), a split can occur at this site and a wide group of degradation products can be formed [11] . Reduction in the B ring and epimerization at C 3 was also observed [16] . The previously mentioned 14-dehydroxylation was found also in humans [18] . Although no report of conjugates in humans exist, it appears improbable that they would not be formed. Thus it is obvious that in evaluation of the metabolic profile of ecdysteroids, it is necessary to take account of the number of double bonds in the molecule, the configuration of substituents, their structure and number.
Acute toxicity of ecdysteroids is low for mammals. LD 50 values of 6.4 g/kg (i. p.) and  9 g/kg (p. o.) in mice were recorded [14] . In this regard, the compound is not toxic, but the question of chronic toxicity (genotoxicity and incidental mutagenity) is still not answered.
Occurrence and sources
A deeper study of ecdysterone necessitates a stable availability of sufficient amounts of the substance. Ecdysteroids have been reported in several hundreds of vascular plants [19] , but after evaluation of this literature data, it is possible to say that ecdysterone occurs minimally in one [23, 24] , Pfaffia glomerata [25] , P. stenophylla [26] , Rhaponticum uniflorum [27] , and Serratula tinctoria dry roots [28] , and the aerial parts of Serratula coronata [29, 30] , S. inermis [31] and Diploclisia glaucescens [32] . Consideration has also been given to the possibility of ecdysterone production by tissue cultures derived from roots of Ajuga reptans 'Atropurpurea´ infected with Agrobacterium rhizogenes MAFF-03-01724 strain [33] , which provide up to 0.0195% of ecdysterone in fresh tissues. Extraction with organic solvents is used for the isolation and purification of this type of substance [34] . Data are also available about the possible use of supercritical fluid extraction [22] , but it does not appear that this method would yield higher efficiency than the classical method [35] ; ecdysterone is a relatively polar substance and its desorption from a macromolecular matrix of plant material by carbon dioxide (even if carrier is present) is usually not complete. Although the purification of the plant extract and partition of the ecdysteroid mixture is comparatively laborious [12] , it does not appear that the isolation of ecdysterone in large amounts would have significant commercial problems [36] .
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Pharmacological effects of ecdysterone It has been shown that phytoecdysteroids do not increase blood pressure, have estrogenic, antiestrogenic and androgenic effects, and do not incite virilization [10] . In the case of ecdysterone, a wide group of effects was determined, which can be classified as positive in terms of organism protection against the progression of various degenerative diseases, including the so-called adaptogenic effect {increase of glycogen and protein formation (anabolic processes), increase of sexual activity, growth stimulation (especially by young animals) and improvement of sexual activity}. Favorable influences on metabolic syndrome, including an increase in glucose utilizability, an antidiabetic effect, decrease in cholesterol production and acceleration of its metabolism, antioxidant effects, improvement of nervous system functions, hepatic, cardiac and pulmonary functions, increase of bone tissue regeneration in fracture, immunomodulation, analgesic and anti-invasive effects (counteracting malignancy, microbial and viral agents) can also be considered as practically utilizable effects. Besides these, increase in lactation, improvement of wound healing and epidermis regeneration was determined [10] [11] [12] 37, 38] . Various compositions of patented preparations have been designed for the prevention of rapid ageing, modulation of the course of diseases associated with old age, influence on obesity, atherosclerosis, hypertension (metabolic syndrome), complaints associated with menopause, andropause, and skin defects related to old age [39] [40] [41] [42] [43] [44] [45] [46] . All these make ecdysterone seem like a universal medicinal substance, but this impression is not unique, as, for example flavonoids also interfere with the activity of a wide range of enzymatic systems. All these claims make it necessary to re-evaluate the biological activity of ecdysterone with more detailed studies.
Ecdysterone (and apparently also other pharmacologically tested ecdysteroids) can act as an inducer for gene switch systems, because it shows important features of such systems [47] : 1) It does not appear that it would bind to vertebrate steroid receptors.
2) It has low toxicity to mammalian cells.
3) It shows specificity to the ecdysterone receptor complex. 4) It seems that it is not synthesized by mammalian cells. 5) It is relatively easily distributed intracellularly.
These relationships have been discussed in several recent reviews [10] [11] [12] . However, the results of ecdysterone effects in invertebrates cannot be applied to vertebrates, including mammals (no literature evidence exists).
In this review the effects of ecdysterone are focused only on their impact on negative processes, which finally lead to degenerative disease progression (biological and oxidative stress), and on intervention to the progression of degenerative diseases (neurodegenerative diseases, cardiovascular system affection, metabolic syndrome).
Adaptogenic activity
The term "adaptogenic activity" appeared in the literature during the second half of the last century in connection with the study of plants, like ginseng, by which general beneficial influences on the metabolism of organisms has been expressed by increased tolerance of the organism to stress (this term should not be confused with the term "tonic"). In some cases, the term "anti-stress effect" is actually used. However, this term has not yet been explained in detail at the molecular level as understood in the light of the process itself. Stress, as a general adaptation syndrome, is a complex of a wide group of consequential biochemical reactions, which start immediately after the organism is exposed to an unfavorable external impact, which causes an inversion of its balance. At the beginning of this reaction production of ACTH increases, producing increased levels of glucocorticoids in the blood, the energy sources in tissue depots are mobilized, and metabolic (muscular) activity is increased. It is a complicated mechanism, connected with an intensive metabolism of glucocorticoids {e.g. COR, but also of catecholamines (adrenaline)}, it runs over the hypothalamus-hypophysis-adrenal axis and has many degrees of freedom [48] . The progress of these reactions is rapid, and that is why it is difficult to observe the conversion of substances in tissues and their quantitative levels. The aim of the stress is to ensure survival of the organism after the negative intervention of noxe from the 710 Natural Product Communications Vol. 6 (5) 2011 Cahlíková et al.
external environment. Therefore, the term "anti-stress effect" is wholly inappropriate and so the question arises: What is the adaptogenic effect? The common term "harmonization", which describes the effect of these substances on mammalian organisms, is used rarely. The universal method for the determination of adaptogenic activity, beside the observation of general physical endurance of the tested organisms, would be measurement of the levels of either some enzymes or hormonal metabolites in a specific tissue, but such methods are not yet in place.
The adaptogenic activity of ecdysterone was proven by tests on rats either after immobilization or swimming; a decrease in the involution of the thymicrolymphatic apparatus was observed, but hypertrophy of adrenal glands, decrease of ascorbic acid content, and stomach ulceration did not occur [49, 50] . By comparison of the ecdysterone effect on thymocyte energy metabolism with that of nerobol, more distinctive positive energy changes were observed in mitochondria of cells in suspension culture [51] . By exploration of the effect of ecdysterone on apoptosis induced by hypoxia in HUVECs, the enhancement of expression of VEGF protein in cardiac myocytes of rat with a consequent protective effect on endothelial cells was found [52] . The substance modulates intracellular pools of cyclic purine nucleotides in rats with experimental D-hypovitaminosis. This preceded the modulation of nucleic acid biosynthesis and supposes activation of the effect of ecdysterone on the G-signal (phospholipid system) in the early phase at the expense of interaction with receptors exposed on the plasma membrane of the cells [53] . The capacity of ecdysterone for stimulating erythropoiesis is similar to that of nerobol [54] . Its radioprotective effect is related to its capability to inhibit RNOS formation [55, 56] .
The first physiological function that is affected during the stress is sexual activity. It was observed in male albino rats that ecdysterone improved sexual activity at the early stage of treatment (until 8 th day), and after that a decrease occurred [57] . These results correlate with previous reports that ecdysterone does not show either virilization or estrogenic and anti-estrogenic activity [10] . The level of T in the organism, in fact the ratio of T: DHT, is one of the factors influencing sexuality. It is in direct context to the level of DHEA, epinephral prohormone, which also occurs in testicles. However, this substance is the initial metabolite of estrogens. An increased level of estrogens would have to be found after elicitation of DHEA formation, which was never exemplified after ecdysterone administration, as also indicated in a recent publication [58] . However, the substance can act favorably in males with defective spermatogenesis, improve copulative functions and semen quality, and enhance the sexual functions in the regeneration phase after myocardial infarction [59] . The opinion that it can retard the ageing process exists (it elevates serum levels of SOD and GSHPx, and reduces MDA) [60] .
Anabolic effects
In 2008 a review was published that gave a detailed comparison of the effects recorded over the last 40 years of 30 phytoecdysteroids and common anabolic steroids [58] . In the survey, the problem associated with the ecdysterone anabolic effect was introduced. Russian, Chinese, and partially Japanese research teams are engaged in the study of this substance. These authors have frequently published their results in national journals and languages which have greatly restricted access to the data.
The favorable anabolic effect of ecdysterone is connected to cross-striated muscle formation. Although the direct virilization effect was not proved, and in fact was rejected [10] , data about the positive effect on muscle formation exist. The anabolic steroids express through the second messenger, which enables hormone-receptor complex formation. This complex operates as a transcription factor in the cell nucleus. It facilitates transcription of the genetic code from DNA to RNA and subsequent protein synthesis. A study of the structure-activity relationship of various ecdysteroids showed that the presence of an -OH group at C 2 and C 3 is important, and the presence of an -OH group at C 20 is essential for an anabolic effect. This is enhanced by the presence of an -OH group at C 11 (turkesterone), whereas the presence of such a group at C 5 and an α-position at C 1 results in significant reduction in the anabolic activity (polypodin B) [61] . Ecdysterone is the optimal ecdysteroid for the enhancement of proteosynthesis and its availability. It was found that the substance increases proteosynthesis in skeletal muscle cells (human and murine myotubes) by up to 20%. Increased rat grip strength was observed in vivo. This effect is mediated by phosphoinositide kinase-3, because it is inactivated by its inhibition [62] . The increase of RNA, DNA and protein synthesis in various types of muscles was found in mice. The total effect involves three processes: those related to a nonspecific pre-genome activation of the system of secondary cell mediators; those pertaining to the activation of transcription; and the anabolic action of insulin stimulating the system of secondary messengers, which is followed by phosphorylation and activation of the translation initiation factors [63] . It increases significantly the number of cells in postnatal muscle stem cell culture (myogenic satellite cells were isolated from sheep skeletal muscle). The substance could be used to have an influence on muscle wasting disorders (sarcopenia of aging) and for improvement of physical performance [64] . Ecdysterone also increases muscle fiber size (rat soleus), increases myonuclear numbers in the fibers of normal and regenerating muscle fibers, and it is possible to think of it as an alternative agent to anabolic steroids in muscle atrophy treatment [65] . The mixture with ecdysterone is intended for modulation of GH formation in mammals; the preparation can be used for muscle degeneration, muscle atrophy, cachexia, congestive heart failure, and myocardial infarction [40] . The substance improves proteosynthesis in skeletal muscles of young pig hybrids [66] . Comparison of the effects of ecdysterone with those of the anabolic steroids methylandrostenediol and nerobol (castrated and normal male rats) showed that ecdysterone could be an interesting potential alternative to the anabolics, without violating the endocrine system [66] , even though it does not act as a hormone. Methandrostenolone and ecdysterone caused short term increase of COR content and decrease of STH levels in the blood plasma of the animals; chronic administration decreased the T content. An increased content of COR was found after single and repeated administration of ecdysterone, but other parameters remained unchanged [67] . As well as nerobol, ecdysterone showed an effect on Ca 2+ transport in skeletal muscle cells. An increase of Ca-ATPase activity was observed in the sarcoplasmic reticulum [68] . A decrease of thymus mass and thymic serum factor content appeared after T and methandrostenolone administration to male rats. Ecdysterone did not show androgenic activity and failed to influence thymus involution and decrease the content of thymic serum factor [69] . In a comparison study of the anabolic activity of Ekdisten, Leveton and Prime Plus, ecdysterone was unambiguously the most active (caliperometric measurement). It is possible to combine this substance with proteins and use it in sport nutrition [70] . There are patented preparations containing ecdysterone which show, beside an adaptogenic effect, cardioprotective, antiaggregation, antihypoxic, gastroprotective, thermoprotective and anabolic effects [30, 71] .
Antiulcer activity
Antiulcer activity is significantly related to the adaptogenic properties, because gastric ulceration is a consequence of the COR effect during the stress. Of the tested ecdysteroids, ecdysterone and turkesterone showed the highest activity; both of them increased the RNA and DNA contents of gastric tissue [72] . Ecdysterone combined with omeprazole sodium showed a stronger effect than omeprazole itself [73] . A preparation for the reduction of the risk of gastric ulcer formation has been designed [30] .
Antioxidant activity
Oxidative stress is a negative biological stress effect. Ecdysterone showed antioxidant and radical scavenging activity in various models [74, 75] . For this non-phenolic, but nevertheless interesting antioxidant substance, reaction kinetics were observed in comparison with those of hydroquinone [76] . Ecdysterone antioxidant activity kinetics were determined in vitro in mitochondrial and liposomal membranes. It was found that the combination of α-tocoferol with ecdysterone showed interesting antioxidant activity on the cholesterol saturated membranes [77] . In organisms with D-hypovitaminosis, easier blood serum lipid free radical oxidation occurs in comparison with intact animals. Ecdysterone showed an antioxidant effect under these conditions [78] . Using vitamin D 3 and ecdysterone in vitamin D-deficient animals, both substances displayed antiradical properties, although the effect was stronger in the case of ecdysterone.
Both may cause antiradical effects through the same mechanisms [79] . After the administration of both substances, increased levels of SOD were found. The contribution to their antioxidant action is possible via modification of the mitochondrial membrane through its lipid content and changing of its cholesterol: phospholipids ratio [80] . Practically, ecdysterone could be used for lung reperfusion injury, as an experiment carried out in a rat model of lung reperfusion showed; the substance lowered ACE and MDA levels and pushed up the levels of SOD; it was more potent then COR [81] . It is necessary to have in mind that ecdysterone is non-toxic to the organism.
Neuroprotective activity
The effects were monitored of ecdysterone on cultured rat cortical neurons using the whole cells recording technique. According to the voltage and current clamp conditions ecdysterone is not able to produce either current changes or any changes in the membrane potential. However, the compound dose-dependently potentiated the GABAinduced current and hyperpolarization (blocked by bicuculline). The results suggest that ecdysterone acts on the modulatory site of the GABA receptor and potentiates GABAnergic inhibition in rat cortical neurons [82] . Investigation of the effect of ecdysterone on proliferation and differentiation of rat hippocampal neural stem cells in vitro, showed that high doses of ecdysterone (400 and 800 mg/L) markedly inhibited the proliferation of these cells, while a dose of 200 mg/L markedly increased neurogenesis [83] . The substance can be applied for inducing neuronal differentiation of mammalian stem cells, and is helpful for research on stem cell transplantation for disease treatment and damage repair of the central nervous system [84] . Cerebral neurons protective agents contain ecdysterone; this agent could be useful for prophylaxis and therapy of dementia, mental and behavioral disorders. Ecdysterone markedly reduces glutamate-induced death of cerebral cortex cells isolated from fetus of rat [85] .
The possibility of inhibition of fibril formation and the neurotoxicity of aggregated amyloid beta-protein fragment 1-42 was studied in an in vitro experiment on neurons from rat embryo cortex. When the neurons were premedicated with either ecdysterone or vitamin E, their viability was increased in comparison with the control, and the LDH release of neurons was decreased, both in a concentrationdependent manner [86] . Ecdysterone can act as a protective agent against Aβ25-35-induced PC12 cell cytotoxicity; this effect might be related to the increase of SOD and GSH-Px activities and the decrease of MDA resulting from the ecdysterone pretreatment [87] .
Ecdysterone can be markedly of use in the study of betaamyloid protein (Abeta) formation and metabolism. Abeta deposition is one of the characteristics of Alzheimer's disease (AD). Beta-secretase (BACE1) is essential for Abeta biosynthesis. Although inhibition of BACE1 is 712 Natural Product Communications Vol. 6 (5) 2011 Cahlíková et al. considered a valid therapeutic target for AD, the enzymatic dynamics of BACE1 in regulating APP processing and Abeta generation has not yet been fully defined. To examine this issue, tightly controlled inducible BACE1 gene expression was established in the neuronal cell line N2ABP1 and the non-neuronal cell line E2BP1 using an ecdysone-inducible system. The BACE1 protein level was increased in a time-and dosage-dependent manner in the inducible BACE1 stable cells by treatment with inducer ponasterone A (ecdysterone was also studied) [88] . Some ecdysteroids are also used for the study of some types of glutamate receptors, but ecdysterone has not been studied yet. However, stable and inducible expression of human metabotrophic glutamate receptor types 2, 5, and 8 by ponasterone A was achieved in HEK293 cells using the ecdysone inducible system. Data suggest that the ecdysone system has a number of characteristics that make it well suited for expressing mGluRs and that the combined use of this system and chimeric G proteins allows receptors to be characterized using a rapid and straightforward Ca 2+ assay [89] . Regarding the similar structure of ecdysterone, comparable activity could be expected. Another study established a non-neuronal cell line that stably and inducibly expressed recombinant NMDA receptors (NRs) composed of rat NR1a/NR2A subunits. To check inducibility, NR2A subunit expression in D5/H3 cells treated with the inducing agent muristerone A was compared with that in non-induced cells. This cell line, which stably and inducibly expresses recombinant NR1a/NR2A NMDA receptors, can be a useful tool for testing NMDA receptor antagonists and studying their subunit selectivity [90] .
Ecdysterone produces a positive effect on learning and memory, which was found by the method of the step-down test (using the passive avoidance response principle) in mice. It also prolonged the survival time of mice under the condition of closed normobaric hypoxia, and thus protected them against acute cerebral hypoxia. These results suggested that ecdysterone protected mice against amnesia, which has potential medicinal value [91] .
Ecdysterone protected mice against acute cerebral hypoxia and inhibited the production of lipid peroxides in brain tissue caused by cerebral hypoxia both in vivo and in vitro. The compound protected the animals against acute cerebral ischemia, cerebral ischemia-induced hypothermia, and cerebral ischemia damage-caused amnesia, and decreased the calcium content in cerebral ischemia rat brain. Ecdysterone could also improve the consolidation disruption of memory caused by cerebral hypoxia in mice. [92, 93] . The compound acts antagonistically against amnesia induced by scopolamine [94] , diazepam, and alcohol. The influence of ecdysterone on memory may be related to its antagonistic actions against the positive modulation of either diazepam or alcohol on the GABAnergic nervous system [95] . Ecdysterone produces also antiepileptic effects on tonic convulsion by acting on the modulatory site of GABA A receptors [96] .
Ecdysterone has a neuroprotective effect on focal cerebral infarct injury, which may be related to abatement of the free radical damage, and reduces brain edema in rats following focal cerebral ischemia [97] . The effect of ecdysterone was observed on the level of VEGF protein in the brain, and angiogenesis and neurological function after focal cerebral ischemia in rats. Ecdysterone can definitely induce VEGF expression and angiogenesis in areas around ischemic brain regions in rats with focal cerebral ischemia and promote neurological recovery following injury [98] . By study of the protective effect of ecdysterone on rat acute cerebral ischemia it was found that ecdysterone could reduce the content of MDA, increase the activity of SOD, and have a protective effect against injury due to lipid oxidation following focal cerebral ischemia in rats [99, 100] . The application of ecdysterone in the treatment of cerebrovascular disease (such as cerebral ischemia or vasospasm), improving brain function in dementia, and inhibiting platelet aggregation has been reported
Influence on metabolic syndrome
Studies have shown that ecdysterone can be used for cardiovascular system protection. This is not only due to its adaptogenic and antioxidant effects, as mentioned earlier, but also to other effects that are linked directly with tissue metabolism related to depression of heart and vessel function. Metabolic syndrome is classified as a combination of symptoms, which are usually not uniformly defined, but include reduced level of HDL-cholesterol, elevated level of triglycerides, hypertension, obesity, impaired glucose tolerance and, frequently, insulin resistance. Coagulation and fibrinolysis impairments also occur.
A very promising effect of ecdysterone on the course of metabolic syndrome was found in ovariectomized rats. In doses of 18, 56 and 116 mg/animal/day, ecdysterone did not stimulate the weight of the uterus in experimental animals, and less fat and more muscle were found. TSH, T3 and T4 serum levels remained unmodified, while the level of T4 was elevated, and the level of T3 depressed in the positive control animals (E2 premedication). When using the lowest dose, the LDL serum levels decreased and TAG levels were not elevated (as was observed in the positive control) in the experimental group, but when using the highest dose of ecdysterone, the HDL level increased. These results show a non-estrogenic impact of ecdysterone on the course of metabolic syndrome and sarcopenia. Use for menopausal women with incipient obesity has been suggested [101] . The composition of a preparation for these purposes has been designed. The preparation would be used against age related illnesses (for example, obesity related to the metabolic syndrome, arteriosclerosis, hypertension, osteoporosis, menopause and andropause troubles [46] . Other preparations designed for this purpose contain extract of Chenopodium quinoa, which contains ecdysterone [102, 103] . Biological 
Antidiabetic activity
A range of experimental models has been used for evaluation of the ecdysterone effect on glucose metabolism and insulin secretion. The HepG2 cell line is one of them. After ecdysterone application to the medium (final concentration in medium 10 -6 -10 -4 M), glucose consumption was increased by 44-77%. The βTC3 cell line was also used to observe insulin secretion. Insulin had no effect on the glucose level lowering of ecdysterone, and βTC3 cells were not stimulated by ecdysterone. It is obvious that ecdysterone is capable of lowering the glucose level in hepatocytes, and this effect is insulin-independent, but it has no effect on insulin secretion [104, 105] . After application of ecdysterone to these HepG2 insulin resistant cells (resistance induced by high insulin concentration), a significant increase in insulin receptor protein was observed. The increase of insulin resistance by ecdysterone can be related to both the insulin-resistant cells transduction signal and significant protein expression [106] . The protein expression of PI3K and GLUT-4 can also be markedly increased. Ecdysterone can improve their sensitivity by upregulating the expression of insulin signaling proteins, such as Pl3K and GLUT-4 [107] . This lowering potency of insulin resistance in cells is similar to that of pioglitazone [108] . The HepG2 cell model is suitable for the study of insulin resistance by the strategy of comparative proteomics. Ecdysterone, which is, according to recent studies, the substance that increases cell insulin sensitivity in the glucose transport process, interferes in the metabolism of many proteins and kinases that correlate with insulin resistance. It represents a suitable model substance for further studies on the function of these target proteins [109] . The mechanism of ecdysterone action is linked with more intensive utilization of glucose by tissues (a shift to aerobiosis), in the process of energetic supply of stimulating anabolic metabolism; this effect was also observed with other ecdysteroids (silenoside A, cyasterone and turkesterone) [110] .
In the studies with ecdysterone and nerobol it was shown that in animals with alloxan diabetes, ecdysterone initially normalized the lipid fractions that play a structural role in the mitochondrial membrane structure. Nerobol normalized the levels of minor and monoacyl phospholipids. Ecdysterone acted like turkesterone [111] . In the study of the effects of both substances on insulin regulatory function (model of insulin resistance in rats induced by either COR or during alloxan-induced insulin insufficiency), it was found that both substances increased the reactivity to insulin and increased the sensitivity of adipose tissue to this hormone in alloxan diabetic animals. They did not affect insulin secretion, but rather stimulated protein synthesis in cells [112] .
For a study of both types of diabetes mellitus it is advisable to observe the development of oxidative and nitrosative stress, and the metabolism of some cations. The inhibition of both types of stresses by ecdysterone (cardio-and vaso-protective) was observed in experimental (streptozotocine) type I diabetes. A new mechanism has been proposed for iNOS activation involving prostaglandin and tetrahydrobiopterin synthesis stimulation by ecdysterone. This was due to stimulation of enzymatic degradation of sphignoside-1-phosphate, an effective regulator of iNOS, COX, and GTP-cyclohydrolase in the cardio-vascular system [113] . During the observation of the protective effect of ecdysterone on heart mitochondria isolated after streptotozicine-induced diabetes, the generation of NO and superoxide was recorded. It was found that ecdysterone reduces diabetes-induced mitochondrial damage and protects the organelles against oxidative and nitrosative stress, and thus may contribute to the treatment of several age-related disorders [114] . The normalization effect of ecdysterone on plasma glucose levels during chronic administration to streptozotocine rats depends evidently on inhibition of non-constitutive NO synthesis by Ca 2+ -independent iNOS and NADPdependent nitrate reductase, as well as inhibition of Larginine degradation. The mechanism thus up-regulates Ca 2+ -dependent constitutive NO synthesis by either eNOS or mitochondrial nNOS in heart and aorta of rats [115] . Chronic hyperglycemia, which developed in streptozotocine diabetes rats, is accompanied by development of severe endothelial dysfunction, as well as by disturbed non-hem iron metabolism. Chronic administration of ecdysterone inhibits this hyperglycemia progression by its effect on non-hem iron metabolism. These data suggest the mechanism for ecdysterone protection of streptozotocineinduced hyperglycemia and ischemia [116] . In the study of more than 1000 substances as candidates for study of potential diabetic neuropathy drugs, 25 substances were chosen, among which ecdysterone occurs. It shows its ability to protect against the increase of superoxide generation induced by hyperglycemia in dorsal root ganglia. The substance could become a lead structure for design of a reasonable therapeutic approach for these serious diabetes complications [117] .
From a practical point of view, a number of suggestions have been published for formulations containing ecdysterone that should solve the problems with the glucose tolerance change and diabetes progress inhibiting insulin resistance [39] . A mixture containing ecdysterone and other major ecdysteroids from Ajuga turkestanica acts hypoglycemically and is reportedly comparable in effect to that of maninil [118] . A similar preparation of ecdysterone and other ecdysteroids providing an antidiabetic effect is based on Cyanotis arachnoidea [119] . Other preparations have been designed containing ecdysterone and inocosterone [120, 121] .
Influence on cardiovascular system
Ecdysterone inhibits oxidative and nitrosative stresses and hence acts as a cardio-and vaso-protective agent in experi- [113] . The substance inhibits mitochondrial permeability transition pore opening in mitochondrial cardiomyocytes of aging rats [122] .
Ecdysterone can be applied for apoptosis of vascular endothelial cells (ECV-304) induced by sodium arsenite. It inhibits the elevation of ICAM-1 expression in endothelial cells in response to arsenite, but does not intervene in arsenite increased oxidative stress levels. It can prevent this apoptosis to a certain extent [123, 124] . Ecdysterone also lowered apoptosis of HUVECs when induced in various ways (hypoxia [52] , endotoxin [125] ), and protected these cells against TNF-α damage [126, 127] . Ecdysterone was able to stimulate HUVEC proliferation in a dose dependent manner [128] . The results of a study describing vascular endothelial cell injury in rats after scalding showed a protective effect of ecdysterone on these cells [129] .
The effect of ecdysterone was also observed in connection with its impact on collateral formation in rat acute myocardial infarction and VEGF expression. Ecdysterone can facilitate the establishment of collateral circulation in heart and improve microvascular blood flow in the infarction zone by up-regulation of VEGF protein expression [130] .
Ecdysterone (in a mixture with 25S-inokosterone) has been designed as a preparation for reduction of platelet aggregation [71] . It can be used prophylactically for decrease of blood viscosity and for improvement of rheological properties of erythrocytes [131] . Serpisten (ecdysteroid concentrate from the aerial parts of Serratula serrulata with a minimum content of 75% ecdysterone and10% 25S-inocosterone) has been designed as an antihyperlipidemic and anti-ischemic agent useable for metabolic disorders of blood lipids, treating dyslipidemia, ischemic heart disease and for rehabilitation of an organism after post-infarction conditions [120] .
Ecdysterone eliminates heart arrhythmia (rat, cat) caused either by aconitine or by ligation of the descending branch of the left coronary artery; it prevents the development of fibrillation and improves the hemodynamic parameters of the heart and heart contractility [132] . In addition to its antiarrhythmic effect, it is possible to use ecdysterone for prevention and treatment of coronary arteriosclerotic heart disease, myocardial ischemia, reperfusion injury and heart injury [133, 134] . The substance, administered after induced myocardial infarction in rat, can alleviate the infarction symptoms via promoting myocardial expression and regeneration of capillary vessels and increasing coronary blood flow [135] .
The protection of the circulatory system is not focused only on the heart region, but also on the brain vascular system. Ecdysterone is useable for treatment of cerebro-vascular disorders (cerebral ischemia or vasospasm) and improves cerebral functions in dementia [136] .
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Conclusion The professional literature provides evidence that the pharmacological effects of ecdysterone (and other ecdysteroids) on mammals are positive and that this compound is able to influence a number of their physiological functions favorably and can prevent the progress of some serious diseases. Despite all this positive information it is not possible to impute exclusive effects to this substance, as can be found in some internet sources (especially in the statements of some companies producing sports nutrition). Presently, ecdysterone is a component of novel food type preparations, the use of which brings no negative effects on human health. However, until extensive, randomized, double-blind studies on the various biological effects have been completed, accompanied by all the required analyses demanded for new drugs, it is possible to think of this compound only as a potential candidate. Within the scale of these studies it is necessary to clarify not only the molecular mechanisms of a single effect, but also its possible intervention in gene expression and to study the risk of this substance in following generations. Ecdysterone is a commerciallyavailable compound without significant problems, and, therefore, the implementation of these studies is realizable. However, the question as to whether there is any interest in proceeding with this compound as a new drug has not been answered yet. If we consider the present policy of new drug development, attention will be paid to it if it brings new crucial effects on human health or if it will be the source of important diagnostic procedures. It appears that ecdysterone could meet such requirements as a novel inducible gene expression system and for methods of modulating gene expression in a host cell described for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic plants and animals. If the results in the research in this area were applicable to either the therapeutic system or commercial possibilities of gaining desirable cell lines or compounds, then the possibility of additional uses of this interesting substance as a real drug in the areas which are mentioned in this review can open.
